You are here

Bellus Health

A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees

LinkedIn

Fri, 03/22/24 - 10:50 am

After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset

Fierce Biotech

Thu, 11/30/23 - 10:07 am

Biopharma’s green shoots thriving in summer sun as deal activity returns

Fierce Biotech

Tue, 07/11/23 - 11:18 pm

Siglion Therapeutics

DiCE Therapeutics

Heightened US antitrust fears rattle biopharma

EP Vantage

Wed, 05/17/23 - 10:12 am

Horizon Therapeutics

Prometheus Biosciences

Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A

Fierce Pharma

Tue, 04/18/23 - 10:10 pm

Prometheus Biosciences

GSK coughs up $2B for Bellus Health

Medical Marketing and Media

Tue, 04/18/23 - 10:24 am

Biopharma’s stock market winners of 2021 revealed

EP Vantage

Wed, 01/12/22 - 10:50 am

Moderna Therapeutics

Bicycle Therapeutics

Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis

Endpoints

Mon, 12/13/21 - 11:06 am

Bellus says its Merck cough rival passed a PhIIb test after earlier flop, but investors can't make up their minds

Endpoints

Mon, 09/13/21 - 10:40 am

clinical trials

Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street

Endpoints

Mon, 07/6/20 - 10:24 am

clinical trials

Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug

Endpoints

Tue, 09/3/19 - 11:30 pm

CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA

PR-Canada.net

Sat, 12/18/10 - 01:55 pm

Celtic Therapeutics

rheumatoid arthritis